JNJ vs ELV
By Alex · Tickerpine
Johnson & Johnson vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ELV |
|---|---|---|
| Price | $263.81 | $439.95 |
| Market cap | $635.07B | $95.41B |
| P/E ratio | 40.0 | 18.7 |
| ROE | 20.02% | 11.48% |
| Profit margin | 16.20% | 2.55% |
| Revenue growth | 5.90% | 1.40% |
| Dividend yield | 2.03% | 1.56% |
| Beta | 0.21 | 0.71 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ELV in plain English
- JNJ is the bigger company — about 6.7× the market cap of ELV.
- ELV is cheaper on earnings (P/E 18.7 vs 40.0).
- JNJ earns a higher return on equity (20% vs 11%).
- JNJ is growing revenue faster (6% vs 1%).
- JNJ has the higher dividend yield (2.03% vs 1.56%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.